News About: Pharm. Industry
Pfizer Korea Defends Reported Market Share Decline of Novarsc
Pfizer Korea defends its position on the reported sharp decline in the domestic market share of Novarsc, by stating that the individual claims on the substitution rates of the original product made by its competing ge...
Iressa Proven for Extended Survival Rates among Asians
AstraZeneca Korea recently announced the results from the first-level intermediate analysis of ISEL (Iressa Survival Evaluation in Lung cancer) Study, an international clinical trial conducted against 1,692 patients w...
Number of Pharmaceutical Advertisements Up 9.5% in 2004
The total number of pharmaceutical advertisements that were reviewed for their appropriateness by the Korea Pharmaceutical Manufacturers Association (KPMA) was 438 in Year 2004, up 9.5% from Year 2003.
Out of 438 r...
Innovara Korea Launches Operation Effective January
Innovara Korea, a domestic branch of a global strategic consulting and management development corporation based in the United States, has launched its business operation effective January under a leadership of Bae Jon...
Market Gives Positive Reaction on Hanmi's Financial Objectives
In response to Hanmi Pharmaceutical's recent announcement on its revenue and profit plans for Year 2005, Sejong Securities reported on January 5th that Hanmi's financial objectives are expected to be achieved based on...
Multinational Companies with Revenue Growth Plans for New Year
It is expected that many of multinational pharmaceutical companies operating in Korea will drive higher revenues for the new year, where the majority of them came short of their last year's revenue objectives due to r...
Wave of Domestic New Drug Releases Expected
According to the Korea Drug Research Association (KDRA)'s latest report on the domestic pharmaceutical companies of their new ethical product research and development activities, the number of new drug releases is exp...
Cellbiotech to Launch Clinical Study of AD Treatment
Cellbiotech Co., a domestic biotechnology venture company, announced on January 4th that it has launched a clinical study of its novel atopic dermatitis (AD) treatment using lactobacillus, which is commonly used for t...
Extra-Strength Cozaar Plus Now Available
MSD Korea's Cozaar Plus-F Tab, with its active ingredients of 100mg losartan (angiotensin II receptor antagonist) and 25mg hydrochlorothiazide (diuretic), is now available in the domestic anti-hypertension treatment m...
Yuhan Joins Efforts in Providing Relief Aids
Yuhan Corporation joins the list of pharmaceutical companies, both domestic and multinational, to lend its humanitarian aid to the disaster-stricken areas in the Southeast Asia.
In its January 3rd announcement, the...
